Real-world data of olaparib maintenance therapy in patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer: Final results of the C-PATROL study

被引：0
|
作者：
Marme, F. [1 ]
Hilpert, F. [2 ]
Welslau, M. [3 ]
Grabowski, J. P. [4 ,5 ]
Schneeweiss, A. [6 ,7 ]
Hartkopf, A. D. [8 ]
Becker, S. [9 ]
Runnebaum, I. [10 ]
Bauerschlag, D. [11 ]
Fasching, P. [12 ]
Brandi, C. [13 ]
Rehbein, J-K. [14 ]
Glowik, R. [15 ]
Sehouli, J. [16 ]
机构：
[1] UMM Univ Klinikum Mannheim, Dept Gynecol Oncol, Med Fak, Mannheim, Germany
[2] Krankenhaus Jerusalem, Mammazentrum, Hamburg, Germany
[3] Klinikum Aschaffenburg, Hamato Onkol Schwerpunktpraxis, Aschaffenburg, Germany
[4] Univ Klin Charite, Dept Gynecol, Berlin, Germany
[5] Campus Virchow Klinikum, Berlin, Germany
[6] Univ Hosp, Div Gynecol Oncol, Natl Ctr Tumor Dis NCT, Gynecol Oncol, Heidelberg, Germany
[7] German Canc Res Ctr, Heidelberg, Germany
[8] Univ Hosp Tuebingen, Ctr Womens Hlth Dept, Tubingen, Germany
[9] Goethe Univ Frankfurt Main, Dept Obstet & Gynecol, Campus Westend, Frankfurt, Germany
[10] Friedrich Schiller Univ Jena, Gynecol & Reprod Med, Jena, Germany
[11] Univ Hosp UKSH, Gynecol Oncol, Kiel, Germany
[12] Univ Klinikum Erlangen, Dept Gynecol & Obstet, Erlangen, Germany
[13] Agaples Med Versorgungszentrum Frankfurt gGmbH, Frauenheilkunde Gynakol, Frankfurt, Germany
[14] Stadt Krankenhaus Kiel GmbH, Frauenklin, Kiel, Germany
[15] AstraZeneca GmbH, Med Affairs, Hamburg, Germany
[16] Charite, Gynecol, Berlin, Germany
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1979
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
802P
引用
收藏
页码：S535 / S536
页数：2
相关论文
共 50 条
  • [1] Overall survival in patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer (PSROC) treated with olaparib maintenance: Real-world data of the C-PATROL study
    Marme, Frederik
    Hilpert, Felix
    Welslau, Manfred
    Grabowski, Jacek P.
    Schneeweiss, Andreas
    Hartkopf, Andreas D.
    Bauerschlag, Dirk
    Fasching, Peter A.
    Brandi, Christiane
    Rehbein, John-Kilian
    Glowik, Regina
    Sehouli, Jalid
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Real-world experience of olaparib as maintenance therapy in BRCA-mutated recurrent ovarian cancer
    Angela Cho
    Jeong-Yeol Park
    Shin-Wha Lee
    Dae-Yeon Kim
    Dae-Shik Suh
    Jong-Hyeok Kim
    Yong-Man Kim
    Young-Tak Kim
    Archives of Gynecology and Obstetrics, 2021, 304 : 1055 - 1063
  • [3] Real-world experience of olaparib as maintenance therapy in BRCA-mutated recurrent ovarian cancer
    Cho, Angela
    Park, Jeong-Yeol
    Lee, Shin-Wha
    Kim, Dae-Yeon
    Suh, Dae-Shik
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 304 (04) : 1055 - 1063
  • [4] Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study
    Bourien, Heloise
    Lefevre, Leila Bengrine
    Mouret-Reynier, Marie-Ange
    Asselain, Bernard
    Lucas, Brigitte
    Gavoille, Celine
    Cornila, Corina
    Gavoille, Laurene
    Colomba, Emeline
    Patsouris, Anne
    Fabbro, Michel
    Chakiba, Camille
    Toussaint, Philippe
    Simon, Helene
    Berton, Dominique
    Garbay, Delphine
    Tixidre, Claire Garnier
    Coeffic, David
    Morvan, Aurelie
    Collard, Olivier
    Rouge, Thibault De La Motte
    ANTICANCER RESEARCH, 2023, 43 (02) : 653 - 662
  • [5] Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
    Ledermann, Jonathan
    Harter, Philipp
    Gourley, Charlie
    Friedlander, Michael
    Vergote, Ignace
    Rustin, Gordon
    Scott, Clare
    Meier, Werner
    Shapira-Frommer, Ronnie
    Safra, Tamar
    Matei, Daniela
    Macpherson, Euan
    Watkins, Claire
    Carmichael, James
    Matulonis, Ursula
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15): : 1382 - 1392
  • [6] Challenges in economic modeling of anticancer therapies: an example of modeling the survival benefit of olaparib maintenance therapy for patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer
    Hettle, Robert
    Posnett, John
    Borrill, John
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (07) : 516 - 524
  • [7] EFFICACY AND SAFETY OF MAINTENANCE OLAPARIB BY PATIENT AGE IN NON-GERMLINE BRCA-MUTATED PLATINUM-SENSITIVE RELAPSED OVARIAN CANCER IN OPINION
    Skof, E.
    Bjurberg, M.
    Rubio Perez, M. J.
    Davidson, D.
    Blakeley, C.
    Bennett, J.
    Poveda, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A202 - A203
  • [8] REAL WORLD OUTCOMES OF OLAPARIB MAINTENANCE THERAPY IN PATIENTS WITH BRCA1/2-MUTATED PLATINUM-SENSITIVE EPITHELIAL OVARIAN CANCER
    McLaren, A.
    White, M.
    Cartwright, D.
    Brown, J.
    Randhawa, M.
    Roxburgh, T.
    Glasspool, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A166 - A166
  • [9] BUDGET IMPACT FOR OLAPARIB MAINTENANCE THERAPY FOR BRCA-MUTATED PLATINUM SENSITIVE RECURRENT OVARIAN CANCER IN PERU
    Torres Toala, F. G.
    Solorzano, J.
    Baldi, J.
    VALUE IN HEALTH, 2018, 21 : S22 - S22
  • [10] BUDGET IMPACT FOR OLAPARIB MAINTENANCE THERAPY FOR BRCA-MUTATED PLATINUM SENSITIVE RECURRENT OVARIAN CANCER IN PANAMA
    Torres Toala, F. G.
    Solorzano, J.
    Baldi, J.
    Castillo-Fernandez, O.
    VALUE IN HEALTH, 2018, 21 : S22 - S22
12345